Capstone Investment Advisors
MRK icon

Capstone Investment Advisors’s Merck MRK Stock Holding History

Capstone Investment Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.34M Buy
61,000
+28,300
+87% +$3.27M 0.01% 349
2025
Q4 		$3.44M Sell
32,700
-49,600
-60% -$4.66M 0.01% 464
2025
Q3 		$6.91M Buy
82,300
+31,700
+63% +$2.61M 0.01% 392
2025
Q2 		$4.01M Sell
50,600
-8,900
-15% -$707K 0.01% 438
2025
Q1 		$5.34M Sell
59,500
-254,700
-81% -$23.8M 0.01% 431
2024
Q4 		$31.3M Buy
314,200
+39,900
+15% +$4.11M 0.08% 156
2024
Q3 		$31.1M Sell
274,300
-16,700
-6% -$1.98M 0.09% 128
2024
Q2 		$36M Sell
291,000
-4,700
-2% -$605K 0.11% 118
2024
Q1 		$39M Sell
295,700
-45,600
-13% -$5.62M 0.14% 103
2023
Q4 		$37.2M Buy
341,300
+217,600
+176% +$22.6M 0.11% 131
2023
Q3 		$12.7M Buy
123,700
+72,200
+140% +$7.78M 0.06% 233
2023
Q2 		$5.94M Buy
51,500
+13,900
+37% +$1.58M 0.03% 345
2023
Q1 		$4M Sell
37,600
-21,900
-37% -$2.36M 0.02% 418
2022
Q4 		$6.6M Sell
59,500
-78,500
-57% -$8.02M 0.05% 315
2022
Q3 		$11.9M Buy
138,000
+2,400
+2% +$214K 0.07% 197
2022
Q2 		$12.4M Sell
135,600
-211,600
-61% -$18.8M 0.06% 214
2022
Q1 		$28.5M Sell
347,200
-349,700
-50% -$27.6M 0.08% 192
2021
Q4 		$53.4M Buy
696,900
+129,600
+23% +$10.3M 0.09% 187
2021
Q3 		$42.6M Buy
567,300
+127,000
+29% +$9.66M 0.08% 210
2021
Q2 		$34.2M Buy
440,300
+59,142
+16% +$4.4M 0.08% 222
2021
Q1 		$28M Buy
381,158
+202,474
+113% +$14.9M 0.08% 219
2020
Q4 		$13.9M Sell
178,684
-33,955
-16% -$2.6M 0.05% 317
2020
Q3 		$16.8M Buy
212,639
+32,488
+18% +$2.54M 0.09% 204
2020
Q2 		$13.3M Buy
180,151
+81,953
+83% +$6.17M 0.09% 194
2020
Q1 		$7.21M Sell
98,198
-46,531
-32% -$3.66M 0.12% 187
2019
Q4 		$12.6M Sell
144,729
-44,854
-24% -$3.68M 0.07% 296
2019
Q3 		$15.2M Buy
189,583
+16,873
+10% +$1.35M 0.1% 191
2019
Q2 		$13.8M Buy
172,710
+12,785
+8% +$979K 0.1% 213
2019
Q1 		$12.7M Buy
159,925
+55,649
+53% +$4.16M 0.12% 177
2018
Q4 		$7.6M Buy
104,276
+34,479
+49% +$2.43M 0.09% 175
2018
Q3 		$4.72M Buy
69,797
+61,623
+754% +$3.93M 0.05% 258
2018
Q2 		$473K Buy
+8,174
New +$461K 0.01% 486
2017
Q2 		– Sell
-1,153
Closed -$69K – 827
2017
Q1 		$69K Sell
1,153
-733
-39% -$44.5K ﹤0.01% 823
2016
Q4 		$104K Sell
1,886
-11,948
-86% -$699K ﹤0.01% 863
2016
Q3 		$823K Buy
+13,834
New +$809K 0.02% 427
2014
Q3 		– Sell
-136,135
Closed -$7.51M – 481
2014
Q2 		$7.51M Buy
136,135
+82,373
+153% +$4.49M 0.1% 153
2014
Q1 		$2.91M Sell
53,762
-72,417
-57% -$3.75M 0.04% 217
2013
Q4 		$6.03M Sell
126,179
-287,467
-69% -$13.1M 0.07% 164
2013
Q3 		$18.8M Sell
413,646
-22,741
-5% -$1.04M 0.19% 65
2013
Q2 		$19.3M Buy
+436,387
New +$19.5M 0.2% 63

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capstone Investment Advisors's MRK Position: Q1 2026 in Review

Capstone Investment Advisors reduced its Merck (MRK) stake by 80% in Q1 2026, selling an estimated $2.94M and leaving 6,472 shares worth $779K. The position accounts for ﹤0.01% of the portfolio, ranked #953.

Capstone Investment Advisors first reported a position in MRK in Q3 2013 and has held it in 35 quarters since. The position peaked at $13.3M in Q4 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Capstone Investment Advisors held 6,472 shares of Merck worth $779K as of Q1 2026.
  • Capstone Investment Advisors sold 25,432 Merck shares in Q1 2026, an estimated $2.94M.
  • Merck made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #953 holding.
  • Capstone Investment Advisors first reported a position in Merck in Q3 2013 and has held it in 35 quarters since.
  • Capstone Investment Advisors's Merck position peaked at $13.3M in Q4 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.